• Type to search or press enter for full results.
Type to search or press enter for full results.

 

 

HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy
Episode

Niamh Pellegrini and Meredith Vornholt of Nevro

HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy

In this episode, we are privileged to host two outstanding healthcare leaders who can help us learn a new way of managing painful diabetic neuropathy. Niamh Pellegrini is the Chief Commercial Officer at Nevro, and Meredith Vornholt is the Senior Director.
Niamh and Meredith discuss HFX for PDN and how it can help patients suffering from painful diabetic neuropathy. They share insights on leveraging technology to help patient care, employer impact, challenges, patient anecdotes, and much more.
HFX for PDN is the only spinal cord stimulation device approved by the FDA with a specific indication to treat PDN.
Learn more about this innovative treatment in this exciting episode of the Outcomes Rocket podcast, so please tune in!

Want to start your own podcast or offload the busywork of your current podcast to the pros?

Smooth Podcasting is the producer of our podcast. They help us deliver high quality audio, show notes, transcripts, podcast marketing, and so much more. We totally recommend them!

Check out Smooth Podcasting!

Get The Latest In Your Inbox

SUBSCRIBE

HFX for PDN: A Nondrug Solution for Painful Diabetic Neuropathy

About Niamh Pellegrini

Niamh is the Chief Commercial Officer at Nevro. She’s a proven commercial leader with 20 years of experience in the health care industry. Prior to joining Nevro, Miss Pellegrini was Vice President of Global Commercial Operations for Abbott Vascular, CEO and President of Autonomic Technologies, and President of North America at Thoratec Corporation, where she helped return the company to growth prior to his acquisition. She’s got a tremendous track record in health care leadership from a commercial perspective.

About Meredith Vornholt

Meredith is the Senior Director of PDN Marketing.  Meredith joined Nevro in 2020 to lead the commercial launch of Nevro’s Painful Diabetic Neuropathy. Prior to joining Nevro, Meredith worked at Life Scan Inc. and led America’s Marketing and Customer Digital Solutions team. Meredith has had a number of various leadership experiences in the payer and commercial channels with companies like J&Jay and others.

 

 

Things You’ll Learn

  • HFX for PDN is for a new non-drug option for patients suffering from chronic pain related to diabetic neuropathy. 
  • Diabetic neuropathy causes pain in the lower extremities.
  • HFX cloud and HFX coach team use digital solutions and technologies to be able to communicate with patients and provide them with options to optimize their therapy and also to communicate how that patient’s doing and their outcomes back to the physicians that are treating them.
  • Data and algorithms were used to manage patients in a very systematic way and help them get relief in a systematic way. 
  • Diabetes patients who are suffering from painful diabetic neuropathy are actually in primary care. We have to start thinking about expanding the diabetes care team. 
  • The HFX for PDN team has an algorithmic approach to managing therapy. 
  • There are over thirty-four million people diagnosed that have diabetes, and approximately 80 percent of those are diagnosed.
  • There aren’t drugs that are available that can return feeling to your feet once they’ve gone numb.
  • It’s OK to talk about your complications.
  • For diabetes patients, take the initiative, get out there and learn about new options, and then stay on top of what’s new in the space

 

Resources

Website:  https://www.hfxforpdn.com/

LinkedIn

https://www.linkedin.com/in/niamh-pellegrini-5527b36/

https://www.linkedin.com/in/meredith-vornholt-54b46131/